Total Payments
$22,894
2024 Payments
$1,992
Companies
69
Transactions
1,049
Medicare Patients
2,397
Medicare Billing
$263,292
Payment Breakdown by Category
Food & Beverage$22,691 (99.1%)
Education$178.86 (0.8%)
Other$24.30 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $22,691 | 1,043 | 99.1% |
| Education | $178.86 | 5 | 0.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24.30 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $2,539 | 124 | $0 (2024) |
| ABBVIE INC. | $2,434 | 104 | $0 (2024) |
| UCB, Inc. | $1,631 | 75 | $0 (2024) |
| Amgen Inc. | $1,100 | 51 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $1,021 | 65 | $0 (2022) |
| Allergan, Inc. | $960.11 | 44 | $0 (2021) |
| GENZYME CORPORATION | $809.67 | 41 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $711.88 | 43 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $710.58 | 67 | $0 (2021) |
| EMD Serono, Inc. | $603.99 | 28 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,992 | 78 | ABBVIE INC. ($440.70) |
| 2023 | $2,942 | 116 | ABBVIE INC. ($609.96) |
| 2022 | $3,178 | 141 | ABBVIE INC. ($678.68) |
| 2021 | $3,265 | 150 | AbbVie Inc. ($704.39) |
| 2020 | $2,200 | 121 | Teva Pharmaceuticals USA, Inc. ($263.46) |
| 2019 | $2,657 | 137 | Amgen Inc. ($367.64) |
| 2018 | $3,489 | 163 | Teva Pharmaceuticals USA, Inc. ($544.33) |
| 2017 | $3,171 | 143 | Allergan Inc. ($258.05) |
All Payment Transactions
1,049 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: Immunology | ||||||
| 11/21/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $34.59 | General |
| Category: Neuropsychiatry | ||||||
| 11/15/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $37.45 | General |
| Category: Neurology | ||||||
| 11/13/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $31.46 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | VYALEV (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: Neurology | ||||||
| 10/28/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: NEUROLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/17/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: Neurology | ||||||
| 10/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $33.40 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: PAIN | ||||||
| 09/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: IMMUNOLOGY | ||||||
| 09/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: PAIN | ||||||
| 09/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.66 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Neurology | ||||||
| 08/26/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: IMMUNOLOGY | ||||||
| 08/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: PAIN | ||||||
| 08/21/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $31.02 | General |
| Category: Neurology | ||||||
| 08/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 593 | 709 | $227,356 | $68,481 |
| 2022 | 8 | 569 | 651 | $202,714 | $60,619 |
| 2021 | 12 | 620 | 757 | $224,592 | $68,162 |
| 2020 | 14 | 615 | 798 | $223,435 | $66,030 |
Total Patients
2,397
Total Services
2,915
Medicare Billing
$263,292
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 155 | 161 | $80,178 | $21,968 | 27.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 128 | 178 | $45,746 | $16,764 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 102 | 129 | $40,010 | $10,904 | 27.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 93 | $16,647 | $5,822 | 35.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 23 | 23 | $7,561 | $2,430 | 32.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 18 | 18 | $7,849 | $2,200 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $7,344 | $2,099 | 28.6% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 11 | 12 | $6,048 | $1,930 | 31.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $7,361 | $1,756 | 23.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 31 | 32 | $4,608 | $1,391 | 30.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 28 | 28 | $4,004 | $1,217 | 30.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 142 | 143 | $71,214 | $22,493 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 99 | 117 | $37,440 | $9,655 | 25.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 96 | 105 | $26,985 | $8,511 | 31.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 66 | 119 | $21,301 | $6,614 | 31.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $18,990 | $5,022 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 46 | 46 | $15,870 | $4,886 | 30.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 31 | 32 | $4,608 | $1,448 | 31.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 30 | 30 | $4,290 | $1,354 | 31.6% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2022 | 14 | 14 | $2,016 | $634.74 | 31.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 132 | 135 | $68,055 | $21,601 | 31.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 101 | 207 | $37,430 | $11,933 | 31.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 79 | 91 | $29,229 | $8,122 | 27.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 70 | 80 | $20,755 | $6,634 | 32.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 59 | 59 | $24,887 | $6,585 | 26.5% |
About Dr. Bhavik Gedia, MD
Dr. Bhavik Gedia, MD is a Neurology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2011. The National Provider Identifier (NPI) number assigned to this provider is 1871887406.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bhavik Gedia, MD has received a total of $22,894 in payments from pharmaceutical and medical device companies, with $1,992 received in 2024. These payments were reported across 1,049 transactions from 69 companies. The most common payment nature is "Food and Beverage" ($22,691).
As a Medicare-enrolled provider, Gedia has provided services to 2,397 Medicare beneficiaries, totaling 2,915 services with total Medicare billing of $263,292. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Tampa, FL
- Active Since 05/31/2011
- Last Updated 05/17/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1871887406
Products in Payments
- UBRELVY (Drug) $1,202
- APTIOM (Drug) $1,161
- NURTEC ODT (Drug) $1,085
- Briviact (Drug) $1,078
- Aimovig (Biological) $1,060
- AJOVY (Biological) $1,005
- QULIPTA (Drug) $762.06
- AUSTEDO (Drug) $694.78
- TROKENDI XR (Drug) $603.77
- BOTOX (Biological) $503.53
- VYEPTI (Biological) $483.35
- AJOVY (Drug) $452.08
- AUBAGIO (Drug) $449.34
- NUPLAZID (Drug) $390.18
- Rebif (Biological) $362.34
- GILENYA (Drug) $353.36
- EPIDIOLEX (Drug) $318.37
- Fycompa (Drug) $312.03
- EMGALITY (Drug) $311.85
- DUOPA (Drug) $308.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Tampa
Derrick Robertson, M.d, M.D
Neurology — Payments: $2.3M
Neurology $2.3M
Selim Benbadis, Md, MD
Neurology — Payments: $2.3M
Neurology $2.3M
Dr. Mark Cascione, M.d, M.D
Neurology — Payments: $1.9M
Neurology $1.9M
Robert Hauser, Md, MD
Neurology — Payments: $1.5M
Neurology $1.5M
David Rose, M.d, M.D
Neurology — Payments: $1.5M
Neurology $1.5M
Dr. Katherine Standley, Do, DO
Neurology — Payments: $1.3M
Neurology $1.3M